The worst thing that can happen in health-care and biomedical research is politics getting involved in choosing what research needs to be done for what disease, Dr. Elias Zerhouni tells Bloomberg Intelligence analyst Sam Fazeli, explaining how mixing science and politics weakens innovation and public trust. On this episode of the Vanguards of Health Care podcast, Zerhouni, a former NIH director and vice chairman of OPKO Health, unpacks his new book Disease Knows No Politics, warns against cutting US research funding and explains why immigration is vital for scientific leadership. He also dives into OPKO and ModeX’s cutting-edge work on multivalent vaccines and multi-specific antibodies that could change the treatment landscape.

 

The worst thing that can happen in health-care and biomedical research is politics getting involved in choosing what research needs to be done for what disease,&nbsp;Dr. Elias Zerhouni&nbsp;tells Bloomberg Intelligence analyst&nbsp;Sam Fazeli, explaining how mixing science and politics weakens innovation and public trust. On this episode of the Vanguards of Health Care podcast, Zerhouni, a former NIH director and vice chairman of OPKO Health, unpacks his new book&nbsp;Disease Knows No Politics, warns against cutting US research funding and explains why immigration is vital for scientific leadership. He also dives into OPKO and ModeX&rsquo;s cutting-edge work on multivalent vaccines and multi-specific antibodies that could change the treatment landscape.
&nbsp;

Vanguards of Healthcare is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

Vanguards of Healthcare is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

Vanguards of Healthcare by Bloomberg Intelligence

From the NIH to ModeX, Dr. Elias Zerhouni on Science, Politics, and Innovation

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/66881761-ab9d-4fe0-b817-b34c0118821c/transcript